Market Access Views & Analysis

Views & Analysis

Q&A--Fortress-Biotech-on-breathing-new-life-into-abandoned-drugs

Q&A: Fortress Biotech’s Lindsay Rosenwald on breathing new l...

One downside of the explosion in our knowledge about potential drug targets is that many promising candidates are getting left on the backburner.

Views & Analysis

3 key trends shaping the immunology market

From an increase in sales of interleukin inhibitors to the prevalence of biosimilars, this decade has been an eventful one in the immunology industry.

Views & Analysis

5-years-of-biosimilars-in-the-US-Industry-Pulse

5 years of biosimilars in the US: what have we learned?

Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients worldwide.

Views & Analysis

Making real world evidence fit for purpose

Although real world evidence (RWE) is a hot topic in pharma right now, many still question whether it is acceptable to be used in regulatory decision making.

Views & Analysis